Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Can/Fite
Recent news which mentions Can/Fite
Industry Analysts Seemingly Sing Praises For This Stock After Phase III Trial Results
July 14, 2022
Tickers
CANF
JNJ
MRK
PFE
Tags
Partner Content
Biotech
Can/Fite
From
Benzinga
CANF: Beginning to Flex Its Muscles; Initiating With OUTPERFORM Rating, $6.00 Price Target
February 23, 2022
Tickers
CANF
Tags
Can/Fite
General
Partner Content
From
Benzinga
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
Tickers
AMGN
CANF
CELG
PFE
Tags
Can/Fite
General
Partner Content
From
Benzinga
Race to Effective Psoriasis Treatment: Can-Fite's Piclidenoson May Edge Over High-Flying Amgen's Otezla. Here's Why
October 20, 2021
Tags
Benzinga
Market News
Markets
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.